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Caspase proteases are principal mediators of
apoptosis, where they cleave hundreds of proteins.
Phosphorylation also plays an important role in
apoptosis, although the extent to which proteolytic
and phosphorylation pathways crosstalk during
programmed cell death remains poorly understood.
Using a quantitative proteomic platform that inte-
grates phosphorylation sites into the topographical
maps of proteins, we identify a cohort of over
500 apoptosis-specific phosphorylation events and
show that they are enriched on cleaved proteins
and clustered around sites of caspase proteolysis.
We find that caspase cleavage can expose new sites
for phosphorylation, and, conversely, that phosphor-
ylation at the +3 position of cleavage sites can
directly promote substrate proteolysis by caspase-8.
This study provides a global portrait of the apoptotic
phosphoproteome, revealing heretofore unrecog-
nized forms of functional crosstalk between phos-
phorylation and caspase proteolytic pathways that
lead to enhanced rates of protein cleavage and the
unveiling of new sites for phosphorylation.
INTRODUCTION
Proteolysis and phosphorylation are two of the most pervasive
forms of protein posttranslational modification, playing essential
roles in the majority of (patho)physiological processes, including
tissue development, cancer, and cell death (Kurokawa and Korn-
bluth, 2009; Lo´pez-Otı´n and Hunter, 2010). Apoptosis, or pro-
grammed cell death, is orchestrated by a family of cysteine
proteases called caspases, which cleave their protein substrates
after aspartic acid residues (Crawford andWells, 2011; Fuentes-
Prior and Salvesen, 2004; Thornberry and Lazebnik, 1998).
Recent advances in global protease substrate identification
technologies have generated a large inventory of proteins that
are cleaved by caspases during apoptosis, demonstrating426 Cell 150, 426–440, July 20, 2012 ª2012 Elsevier Inc.that as much as 5% of the proteome is subject to caspase-
mediated proteolysis (Arntzen and Thiede, 2011; Crawford and
Wells, 2011).
Protein kinases are prominently represented among caspase
substrates and, in some cases, cleavage activates these kinases
so that they can perform important functions in apoptosis (Kuro-
kawa and Kornbluth, 2009). Caspase-mediated activation of
Rho-associated kinase 1 (ROCK1), for instance, promotes the
characteristic membrane blebbing associated with apoptosis
(Coleman et al., 2001). Kinases can also be inactivated by
caspase-mediated cleavage to block their activity during
apoptosis (Kurokawa and Kornbluth, 2009). The crosstalk
between caspases and kinases also includes the phosphoryla-
tion of caspases to either enhance or suppress their activity
(Kurokawa and Kornbluth, 2009). Likewise, the phosphorylation
of some caspase substrates, notably BID phosphorylation on
Thr59 (which is the P2 residue of the caspase-8 cleavage site)
blocks caspase cleavage (Degli Esposti et al., 2003). These find-
ings suggest that caspase and kinase pathways interact in
intricate ways to influence the balance between cell survival
and death (Janes et al., 2005). Nonetheless, whether a more
global relationship between proteolysis and phosphorylation
exists in apoptosis has not been investigated.
We recently introduced a proteomic method termed
PROTOMAP (short for Protein Topography and Migration Anal-
ysis Platform) that can be used to characterize proteolytic events
in cells by detecting shifts in protein migration through a combi-
nation of SDS-PAGE and mass spectrometry (MS)-based
proteomics (Dix et al., 2008). Using this approach, we identified
over 250 cleaved proteins in apoptotic cells, including 170
proteins that were not previously known to be cleaved by cas-
pases. In the current study, we sought to create an advanced,
quantitative version of PROTOMAP that enables simultaneous
analysis of proteolytic and phosphorylation processes in cells,
such that phosphorylation sites could be directly integrated
into the topographical maps of cleaved proteins during
apoptosis. We applied this method to study the intrinsic
apoptotic cascade in Jurkat T cells, resulting in the identification
of more than 700 cleaved proteins and 5,000 sites of phosphor-
ylation. The integration of these global data sets revealed that
phosphorylation events are enriched on cleaved proteins and
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Figure 1. Quantitative Profiling of Phosphorylation and Proteolytic Pathways in Apoptosis by qP-PROTOMAP
(A) General features of qP-PROTOMAP method as described in the main text. Peptides are colored red and blue to represent signals detected in healthy control
(light) and apoptotic cells (heavy), respectively.
(B) Number of cleaved proteins detected using the original PROTOMAPmethod (Dix et al., 2008) versus qP-PROTOMAP as described in this study. See Table S1
for peptographs of cleaved proteins identified by qP-PROTOMAP.
(C) Distribution of phosphorylation events identified in control and apoptotic cells by qP-PROTOMAP. Phosphorylation events were designated ‘‘control specific’’
or ‘‘apoptosis specific’’ if they showed light/heavy SILAC ratios of >2 or <0.5, respectively (corresponding to log2 values of 1 or 1). Phosphorylation events
displaying light/heavy ratios between these values were designated as ‘‘static.’’
See also Table S2.are clustered around sites of caspase cleavage. We further iden-
tified a cohort of previously unreported phosphorylation sites
that were specific to apoptotic cells, suggesting the existence
of a cell-death-related phosphorylation network. We show using
activity-based proteomic methods that at least a part of this
network is driven by caspase-mediated activation of DNA-
dependent protein kinase (DNA-PK) at early stages during the
time course of apoptosis. Finally, we interrogated the functional
relationship between proteolysis and phosphorylation, uncover-
ing multiple forms of crosstalk that include the caspase process-
ing of proteins to expose new sites for phosphorylation and the
phosphorylation of proteins at the +3 (P3) position of caspase
recognition sequences to dramatically enhance proteolysis by
caspase-8.RESULTS
Quantitative Proteomic Analysis of Phosphorylation and
Proteolysis by qP-PROTOMAP
The proteomic measurement of dynamic posttranslational
modifications, like phosphorylation, requires quantification of
individual peptides, and we therefore sought to combine
PROTOMAP with stable isotopic labeling methods (SILAC; Ong
et al., 2002) for this purpose. We also needed to incorporate a
phosphopeptide enrichment step without sacrificing the protein
size and topography information provided by the SDS-PAGE
step of the original PROTOMAPmethod. The workflow for the re-
sulting quantitative phospho-PROTOMAP (or qP-PROTOMAP)
platform was therefore as follows (Figure 1A): Control andCell 150, 426–440, July 20, 2012 ª2012 Elsevier Inc. 427
apoptotic cells were grown in media containing isotopically light
and heavy amino acids, respectively. Equal quantities of each
cell proteome were then combined and separated by SDS-
PAGE. Next, as in the original PROTOMAP method, gel lanes
were sliced into 22 evenly spaced bands that were digested
in-gel with trypsin to extract peptides. Phosphopeptides were
then enriched via immobilized metal-affinity chromatography
(IMAC) and subjected to reverse-phase liquid chromatography
and MS analysis on an LTQ-Velos Orbitrap. Flow-through from
the IMAC step (containing unphosphorylated peptides) was
also analyzed, and the combined SILAC ratios of unphosphory-
lated and phosphorylated peptides were integrated into quanti-
tative peptographs to provide a complete picture of protein
phosphorylation and proteolysis.
Peptographs for qP-PROTOMAP experiments display de-
tected peptides from left-to-right based on their position in
the primary sequence of their proteins, and from top-to-bottom
depending on the gel band in which they were detected (the
vertical dimension thus represents molecular weight) (Fig-
ure 1A). Phosphopeptides are marked by a circle. For the
purposes of quantitation, each peptide is assigned a color on
a continuum from red to blue reflecting the light/heavy ratio:
peptides exhibiting no-change (1:1 ratio) are displayed in
purple; control- and apoptosis-specific peptides are shown in
red and blue, respectively. To facilitate visual interpretation of
these quantified peptide data, a box plot is provided in the
middle panel (to the right of the peptograph) that displays the
distribution of ratios found in each band. Spectral-count infor-
mation is displayed in a third panel to enable estimation of
the relative abundance of each protein isoform. Most impor-
tantly, because qP-PROTOMAP integrates phosphorylation
sites into the topographical maps of cleaved proteins, the
approach can determine the precise protein isoforms that
possess individual phosphorylation events. Thus, we are able
to identify phosphorylation events that may occur exclusively
on full-length proteins or, alternatively, on fragments of these
proteins generated during apoptosis. We present an example
peptograph and more details on its interpretation in Figure S1
(available online).
For our assessment of crosstalk between proteolysis and
phosphorylation, we induced the intrinsic apoptotic pathway in
Jurkat T cells with staurosporine (‘‘STS’’). Although it might
initially seem counterintuitive to use a broad-spectrum kinase
inhibitor like STS to study phosphorylation events in apoptosis,
we hypothesized that this drug, through the inhibition of many
kinases, might simplify the phosphoproteome to facilitate the
characterization of phosphorylation events that were important
for programmed cell death. Indeed, we, and others, have shown
that STS induces a highly efficient apoptotic cascade in Jurkat
T cells that is essentially complete by 6 hr (Dix et al., 2008;
Na et al., 1996; Stolzenberg et al., 2000), and we therefore
expected that any kinase pathways relevant for this rapid cell
death process would necessarily be insensitive to this drug.
We therefore analyzed STS-treated Jurkat cells at an ‘‘early’’
(2 hr) and ‘‘late’’ (4 hr) stage of apoptosis by qP-PROTOMAP.
In total, 4,521 proteins were detected across both time points,
and 5,034 sites of phosphorylation were quantified on serine,
threonine, or tyrosine residues from 1,624 of the proteins (36%428 Cell 150, 426–440, July 20, 2012 ª2012 Elsevier Inc.of all proteins detected). Peptographs were generated for each
protein at both time points, enabling rapid visual interpretation
of their (1) cleavage status, (2) cleavagemagnitude, and (3) phos-
phorylation status on individual protein isoforms in a time-
dependent manner.
Quantitative Analysis of Cleaved Proteins in Apoptotic
Cells by qP-PROTOMAP
We initially evaluated the performance of qP-PROTOMAP as
a global method for characterizing cleaved proteins, which
were expected to: (1) possess multiple peptides in the parental
protein band that substantially deviate from the 1:1 SILAC ratio
observed for uncleaved proteins, and/or (2) display persistent
protein fragments selectively in apoptotic cells. We developed
abundance thresholds for quantifying the cleavage state of
proteins, and, out of 2,867 proteins that met these thresholds,
744 of them (26%) showed strong evidence of cleavage
(Table S1; see the Extended Experimental Procedures for
details). A majority of the cleaved proteins identified in our orig-
inal PROTOMAP study were also observed to be cleaved by
qP-PROTOMAP (77%, Figure 1B), andwe detected 349 proteins
that had not been previously described in the literature as cas-
pase substrates (Table S1). Considerably more proteins were
found to be cleaved than has been previously reported, both in
absolute number and as a percent of the proteome. This can be
ascribed to the higher accuracy and sensitivity that is achievable
using SILAC quantitation, enabling high-confidence assess-
ments of lower-abundance proteins. As reported previously
(Dix et al., 2008), the majority of cleaved proteins (67%) dis-
played one or more persistent fragments (Table S1).
Quantitative Analysis of the Phosphoproteome
in Apoptotic Cells by qP-PROTOMAP
We next assessed the performance of qP-PROTOMAP as
a global method for characterizing phosphorylation events in
apoptotic cells. Phosphorylation events that showed >2-fold
SILAC ratios in control or apoptotic cellswere defined as ‘‘control
specific’’ or ‘‘apoptosis specific,’’ respectively. We should note
the potential for these phosphopeptide SILAC ratios to be influ-
enced by the cleavage of proteins. For instance, reductions in
protein abundance during apoptosis could indirectly cause
a loss of phosphopeptide signals. Conversely, the stochastic
nature of peptide detection in individual data-dependent MS
runs could result in the identification of a static phosphorylation
event exclusively on one isoform of a protein. We attempted to
address at least some of the complexities by performing
numerous replicates for our phosphoproteomic experiments
(see Extended Experimental Procedures for details), which
yielded rapidly diminishing returns for unique phosphorylation-
site identification with each replicate (Figure S2).
A global analysis of SILAC ratios for the 5,060 phosphoryla-
tion events identified in our combined qP-PROTOMAP data
sets led to several important discoveries. First, a majority of
phosphorylation events (>85%) either showed no change or
were elevated in control cells (Figure 1C). This is not a surprising
result given that we induced apoptosis with the broad-spectrum
kinase inhibitor STS. Even with this mode of inducing apoptosis,
however, we still identified 531 phosphorylation sites that were
apoptosis specific (Figure 1C; Table S2). Striking examples
included the pSer347 and pSer882 events in the retinoblastoma
protein (RB1) (Figure 2A, features ‘‘1’’ and ‘‘2,’’ respectively),
a well-studied tumor suppressor that is known to be cleaved
at two distinct caspase sites following the induction of
apoptosis (Fattman et al., 2001). We identified 18 additional
sites of phosphorylation on RB1, virtually all of which were
control specific (Figures 2A and 2B). Most of these control-
specific phosphorylation events occurred at well-characterized
sites identified in numerous (>10) independent studies as deter-
mined by searches of the PhosphoSite database (Hornbeck
et al., 2011) (Figure 2B); interestingly, however, the apoptosis-
specific pSer347 and pSer882 events had only been reported
rarely in previous phosphoproteomic analysis (%3 times each;
Figure 2B) and, in the case of pSer347, only in Jurkat cells
treated with pervanadate, a known proapoptotic stimulus
(Hehner et al., 1999). These initial data suggested that apoptosis
might activate a special phosphorylation network that is distinct
in content from other cellular processes. We more systemati-
cally assessed this possibility by comparing static/control-
specific and apoptosis-specific phosphorylation events, as
estimated by the absence of annotation of these events in
the PhosphoSite database. Strikingly, close to half of the
apoptosis-specific phosphorylation sites were previously unre-
ported in the literature, whereas less than 15% of the static/
control-specific phosphorylation sites fell into this category (Fig-
ure 2C). Apoptosis-specific phosphorylation events were also
underrepresented among phosphorylations that were frequently
detected in the literature (R5 citations) (Figure 2D). We
conclude from these data that apoptosis leads to the activation
of a specific set of kinases (and/or inactivation of phosphatases)
to create a rare pool of phosphorylation events that are not
observed in healthy cells.
A closer examination of the apoptosis-specific phosphoryla-
tion sites on RB1 uncovered another provocative feature—
both of these events are proximal to known sites of caspase
cleavage (green lines in Figure 2A) that generate persistent frag-
ments detectable by qP-PROTOMAP and western blotting
(Figure 2A). The pSer347 event, for instance, occurs just two
residues upstream (the P3 position) from the scissile aspartate
(Fattman et al., 2001). The pSer882 event is located four residues
upstream of a known scissile aspartate (at the P5 position,
Fattman et al., 2001) and was identified by qP-PROTOMAP on
a half-tryptic peptide ending at this residue, indicating that the
phosphorylation event resides on a caspase-cleaved fragment
of RB1 (in this case, the cleavage event is not expected to
produce a shift in gel migration of RB1 because cleavage occurs
near the C terminus of the protein). These observations led us to
wonder whether such cleavage-site-proximal phosphorylation
events were unique to RB1, or whether they might represent
a more general phenomenon that occurs during apoptosis.
Systems-wide Crosstalk between Proteolysis and
Phosphorylation during Apoptosis
To evaluate how phosphorylation events that occur during
apoptosismight globally intersect with caspase-mediated prote-
olysis, we compiled all of the known sites of caspase cleavage,
including 75 sites that were identified in the current study (TableS3), to give 679 total sites on 566 distinct proteins. Four hundred
and thirteen of these proteins were detected in our analysis of
Jurkat T cells, and we aligned their sequences such that they
were all anchored around the scissile P1 aspartate residue. We
then searched for phosphorylation events in our data sets that
were located 200 residues up- or downstream of the P1 resi-
dues, resulting in the discovery of 675 such phosphorylation
events on 210 proteins. These phosphorylation sites were strik-
ingly clustered in the region immediately surrounding the scissile
aspartate, in particular from the P6 to P60 residues (shaded
region in Figure 3A; also see Table 1). This clustering was evident
not only for apoptosis-specific phosphorylation events, but also
for static and control-specific phosphorylation events (Fig-
ure S2). We furthermore found that known caspase substrates
were more likely to be phosphorylated in Jurkat T cells than
were uncleaved proteins (Figure 3B).
We next asked whether the phosphorylation events that
occurred in apoptotic cells were catalyzed by a specific set
of kinases. To discover kinases that might be activated
during apoptosis, we employed a functional proteomic platform
termed KiNativ. The KiNativ technology uses active site-
directed chemical probes containing biotin-conjugated elec-
trophilic analogs of ATP or ADP for covalent capture of
ATP-binding proteins from proteomes. Conserved lysines in
kinase active sites react with the probes and are then enriched
and quantified with streptavidin chromatography and targeted
MS analysis, respectively (Patricelli et al., 2011; see Extended
Experimental Procedures for details). The majority of kinases
showed reduced KiNativ signals in apoptotic cells (Figure 3C
and Table S4), likely reflecting inhibition by STS. However,
a handful of kinases showed stronger KiNativ signals in STS-
treated cells, the most dramatic of which was DNA-dependent
protein kinase (DNA-PK) (Figure 3C). DNA-PK is known to pref-
erentially phosphorylate serines and threonines that are located
before glutamine residues on proteins ([S/T]-Q motif; Kim et al.,
1999). Consistent with the activation of DNA-PK during
apoptosis, a motif-x analysis (Schwartz and Gygi, 2005) re-
vealed that S-Q phosphorylations were the most overrepre-
sented motifs among the apoptosis-specific phosphorylation
events in our data sets (Figure 3D and Table S4). No such
enrichment of S-Q motifs was observed for static or control-
specific phosphorylation events (Table S4). These proteomic
data were confirmed by western blotting using an antibody
that recognizes p[S/T]-Q motifs, which showed a time-depen-
dent increase in p[S/T]-Q-immunoreactive proteins in apoptotic
cells compared to control cells that peaked at 2 hr post-STS
treatment (Figure 3E).
The [S/T]-Q substrate motif is utilized by other kinases, most
notably ATM and ATR, which, along with DNA-PK, are important
regulators of genome stability and the DNA-damage response
(Kim et al., 1999). No change in ATM or ATR activity was seen
in our KiNativ data (Table S4), but this finding does not rule
out a contribution of these kinases to phosphorylation events
in apoptosis. We more directly tested for this possibility by treat-
ing Jurkat T cells with selective inhibitors of DNA-PK (NU-7441
and NU-7026), ATM (KU5633), or ATM/ATR (CGK733) for 1 hr
prior to induction of apoptosis. Western blotting revealed a
near-complete block of p[S/T]-Q events upon treatment withCell 150, 426–440, July 20, 2012 ª2012 Elsevier Inc. 429
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Figure 2. Identification of a Cohort of Apoptosis-Specific Phosphorylation Events
(A) Western blot and quantitative peptograph for RB1 at 4 hr post-STS treatment. Two apoptosis-specific phosphorylation events were identified at Ser347 (1)
and Ser882 (2). To the right of the peptograph, representative MS1 chromatographs for phosphorylated and unphosphorylated versions of these peptides are
shown in which light (control) and heavy (apoptotic) signals are colored red and blue, respectively. Green lines mark known sites of caspase cleavage (Fattman
et al., 2001) that likely generate the observed N-terminal and internal fragments visible on the peptograph and, in the case of the internal fragment, by western
blotting. Asterisk denotes a nonspecific band on the blot.
(B) Shown are the 39 phosphorylation sites on RB1 listed in the PhosphoSite database, along with the number of literature references for each site. Note that the
two apoptosis-specific phosphorylation events (blue) have been rarely reported in previous studies, in contrast to control-specific phosphorylation events (red),
which were, in general, detected in many previous studies. Below each phosphorylation site, we show the corresponding SILAC ratios. Sites shown in black were
not detected in our study.
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DNA-PK inhibitors, whereas inhibitors of ATM and/or ATR were
without effect (Figure 3F). We also generated two Jurkat T cell
lines with stable shRNA-mediated knockdowns of DNA-PK (Fig-
ure S2) and found that these cells showed substantially blunted
[S/T]-Q phosphorylation following induction of apoptosis (Fig-
ure 3F). Finally, we performed a qP-PROTOMAP study of
apoptotic Jurkat cells pretreated with NU-7441, which resulted
in a two-fold or greater reduction in the majority of p[S/T]-Q
events (60%), with other non-p[S/T]-Q events being minimally
affected (Figure S2). Interestingly, of the p[S/T]-Q events reduced
by NU-7441 treatment, over 80% were apoptosis specific (Fig-
ure S2 and Table S4), which, when combined with our immuno-
blotting results (Figure 3F), indicate that DNA-PK is responsible
for a large fraction of the p[S/T]-Q events observed in apoptotic
cells.
We next investigated how DNA-PK might be activated during
apoptosis. We found that, early in the apoptotic cascade, DNA-
PK relocated from the nucleus to the cytoplasm, where, interest-
ingly, the enzyme was cleaved to generate a stable 150 kDa
C-terminal fragment that contains the kinase domain (Figures
3G and 3H). The appearance of a cleaved form of DNA-PK in
the cytoplasm directly correlated with the increased p[S/T]-Q
immunoreactive proteins (Figure 3E) and the enhanced KiNativ
signals for this kinase observed 2 hr after induction of apoptosis
(Figure 3H, top). Pretreatment of cells with the caspase inhibitor
Z-VAD-FMK blocked STS-induced cleavage of DNA-PK and p
[S/T]-Q events (Figure S2). Previous studies have also reported
the caspase-mediated cleavage of DNA-PK in apoptotic cells
(Casciola-Rosen et al., 1995), but have mostly interpreted this
proteolytic event to inactivate DNA-PK. The assays used in
such studies, however, typically measured DNA-dependent
DNA-PK activity with a peptide substrate (Allalunis-Turner
et al., 1995; Han et al., 1996; Song et al., 1996). Our data support
an alternative model wherein caspase cleavage releases
DNA-PK from genomic DNA to generate an active, truncated
form of the enzyme that traverses into the cytoplasm to catalyze
a large number of apoptosis-specific phosphorylation events.
Caspase Cleavage Can Expose Phosphorylation Sites
Previous studies that have examined the functional effects of
phosphorylation on caspase cleavage with individual protein
substrates in vitro have mostly uncovered instances where
phosphorylation blocks caspase cleavage (Duncan et al., 2010;
Kurokawa and Kornbluth, 2009; To¨zse´r et al., 2003), leading to
a model where phosphorylation serves to ‘‘protect’’ proteins
from proteolytic processing. Many of the apoptosis-specific
phosphorylation events identified in our study, however, did
not appear to conform to this scenario because they were
located on half-tryptic peptides ending in C-terminal aspartates,
the hallmark of caspase cleavage. One such example is SF3B2,
which contains an apoptosis-specific phosphorylation event at
Ser861 that is located at the P2 position adjacent to a site of cas-(C) Approximately 40% of apoptosis-specific phosphorylation events have not be
only 13% of static or control-specific phosphorylation events fall into this cate
(D) Histogram showing the number of literature references found in the Phospho
phosphorylation events. Note that apoptosis-specific events are overrepresented
specific events are overrepresented in the group with many previous identificatiopase cleavage (Figures 4A and 4B). To ascertain whether this
phosphorylation event occurs before or after caspase-mediated
proteolysis, we used a targeted MS approach with isotopically
labeled peptides to measure the four possible forms of the
SF3B2 peptide: (1) uncleaved/unphosphorylated, (2) cleaved/
unphosphorylated, (3) uncleaved/phosphorylated, and (4)
cleaved/phosphorylated. These experiments provided two key
lines of evidence supporting that phosphorylation of Ser861
occurs after caspase-mediated proteolysis. First, the cleaved/
unphosphorylated peptide appeared at an earlier time point
than the cleaved/phosphorylated peptide (Figure 4C). Second,
the uncleaved/phosphorylated peptide was not detected at any
time point, suggesting that the full-length (parental) form of
SF3B2 is not phosphorylated at Ser861. These predictions
were also supported by in vitro substrate assays,wherewe found
that the unphosphorylated, but not phosphorylated peptide
served as a substrate for caspases (Figure 4D and Figure S3).
A broader search of our qP-PROTOMAP data set identified
several additional apoptosis-specific phosphorylation events
that were found exclusively on half-tryptic, aspartate-terminating
peptides (Table 1, Figure S3 and Table S5). One candidate was
a previously unreported phosphorylation event found at the P4
position (S*QTD) on an N-terminal fragment of HCLS1 (Fig-
ure 4E). Similar to what was observed for pSer861 in SF3B2,
phosphorylation of Ser112 completely blocked caspase-3
cleavage of the HCLS1 peptide (Figure 4F and Figure S3). Cas-
pase-8 cleavage was also significantly reduced by phosphoryla-
tion of Ser112, although residual hydrolytic activity was detected
(Figure 4F). These data, taken together, are consistent with
phosphorylation of Ser112 occurring after caspase-mediated
cleavage of HCLS1.
Phosphorylation Can Promote Caspase Cleavage
We next wondered whether phosphorylation might also, in
certain instances, directly promote (rather than block) cas-
pase-mediated proteolysis. We accordingly searched our qP-
PROTOMAP data sets for apoptosis-specific phosphorylation
events that were located on the parental forms of cleaved
proteins in close proximity to sites of caspase-mediated proteol-
ysis. A compelling example was found in the protein KHSRP
(Figure 5A), where we observe an apoptosis-specific phosphor-
ylation event at Thr100 at 2 hr post-STS treatment on the
parental 74 kDa form of the protein (band 6/7), and at 4 hr on
a half tryptic, aspartate (Asp103)-terminating peptide in an
N-terminal 15 kDa fragment (band 21/22) (Figures 5A and 5B,
respectively). pThr100 was thus located at the P3 position
relative to the Asp103 caspase cleavage site. We also detected
the unphosphorylated version of the half-tryptic, Asp103-
terminal peptide in the KHSRP fragment.
To determine the relative kinetics of Thr100 phosphorylation
versus caspase-mediated proteolysis at Asp103 in KHSRP, we
performed a targeted MS analysis using isotopically labeleden reported previously based on PhosphoSite database searches. In contrast,
gory.
Site database for apoptosis-specific (blue) and static or control-specific (red)
in the previously unreported group (zero references), whereas static or control-
ns (>4 references).
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peptides following the protocol outlined above for the SF3B2
protein. In band 6, where the parental form of KHSRP migrates,
we detected the uncleaved/phosphorylated form of the peptide,
which was strongly increased over the first 2 hr following STS
treatment and then decreased thereafter (Figure 5C). In contrast,
the cleaved forms of the peptide in bands 21/22 did not appear
until 2.5 hr and continued to accumulate throughout the
remainder of the time course (Figure 5C). These data indicate
that phosphorylation at Thr100 precedes proteolysis by a
substantial time window during the apoptotic cascade. We
should note that the vast majority of the cleaved peptide was
found in the unphosphorylated form, with only trace levels of
the cleaved/phosphorylated peptide being detected throughout
the time course. Nonetheless, we were intrigued by the comple-
mentary time courses for phosphorylation versus proteolysis, as
well as the similar stoichiometries of the uncleaved/phosphory-
lated and cleaved/unphosphorylated peptides, both of which
peaked at 10% of the total quantity of uncleaved/unphos-
phorylated peptide (Figure S4). These data correlate well with
the low overall magnitude of cleavage for KHSRP (see pepto-
graphs in Figures 5A and 5B) and suggest further that phosphor-
ylation and proteolysis may have a quantitative relationship
wherein phosphorylation at Thr100 promotes caspase proteol-
ysis at Asp103. In this model, the lack of accumulation of the
cleaved/phosphorylated peptide could be explained by rapid
dephosphorylation of pThr100 following caspase cleavage.
We tested whether phosphorylation at Thr100 directly affects
caspase cleavage at Asp103 using in vitro peptide substrate
assays. Caspase-3 hydrolyzed the phosphorylated and unphos-
phorylated KHSRP peptides at equivalent rates (Figure 5D and
Figure S4); caspase-8, however, exhibited a dramatic increase
in hydrolytic activity (>20-fold) for the phosphorylated form of
the peptide (Figure 5D and Figure S4). The increased hydrolytic
activity of caspase-8 could be completely blocked by preincu-
bation with the inhibitor Z-VAD-fmk (Figure S4). These findings
intrigued us because it is known that caspase-8, but not
caspase-3, displays a strong preference for glutamic acid, which
is an approximate isostere of phosphorylated serine/threonine
residues (Pearlman et al., 2011), at the P3 position (Che´reau
et al., 2003; Fuentes-Prior and Salvesen, 2004). These data sug-
gested that caspase-8 may have evolved a special capacity to
accommodate and even prefer phosphorylated residues at theFigure 3. Global Crosstalk between Phosphorylation and Proteolytic P
(A) Phosphorylation events are found near sites of caspase cleavage in apoptotic
cleavage were aligned around their scissile aspartate residues (P1) and the num
enrichment of phosphorylation surrounding scissile aspartate residues is shaded
(B) Caspase-cleaved proteins are more likely to be phosphorylated than uncleav
(C) Kinase activity profiles in Jurkat T cells as measured by KiNativ analysis at 2 h
Table S4 for full KiNativ data sets generated at 1, 2, and 4 hr post-STS treatmen
(D) The most highly overrepresented motifs for apoptosis-specific phosphorylati
(E) Anti-p[S/T]-Q western blot showing increased phosphorylation of [S/T]-Q mo
(F) Anti-p[S/T]-Q blot demonstrating that DNA-PK, but not ATM or ATR kinases,
(G) Quantitative peptograph showing proteolysis of DNA-PK at 2 hr post-STS
catalytic domain.
(H) Confirmation by western blotting that, upon induction of apoptosis, DNA-PK is
from the nucleus (Nuc) to the cytoplasm (Cyto). The cleavage kinetics for DNA-
(bar graph) or p[S/T]-Q immunoreactivity (E).
Error bars represent the SEM. See also Figure S2.P3 position. To further explore this concept, we modeled the
interaction of phosphorylated and unphosphorylated KHSRP
peptides in the active sites of caspase-3 and caspase-8 (Fig-
ure 5E and Figure S4). These models predict a clear interaction
between the pThr100 of the KHSRP substrate and an arginine
residue (Arg177) in caspase-8 that is not found in caspase-3 (Fig-
ure 5E and Figure S4). Arg177 has also been found to interact
with the P3 glutamic acid residue of inhibitors in caspase-8
cocrystal structures (Blanchard et al., 2000; Ekici et al., 2006).
Inspired by this discovery, we searched our qP-PROTOMAP
data for additional examples of apoptosis-specific Ser/Thr phos-
phorylation events occurring at the P3 position of known cas-
pase cleavage sites (Table 1). We have already briefly discussed
another such example - the apoptosis-specific pSer347 in RB1,
which is located at the P3 position adjacent to the Asp350
cleavage site. Utilizing synthetic RB1 peptides, we again found
that the phosphorylated peptide served as a much better
caspase-8 substrate compared to the unphosphorylated variant
(Figure 5F). In this case, caspase-3 also showed improved
activity for the phosphorylated peptide, but exhibited a less
dramatic increase than caspase-8 (Figure 5F). Finally, we
noticed that caspase-3 itself possesses an apoptosis-specific
phosphorylation event, pSer26 (detected at 2 hr post-STS treat-
ment), that is located at the P3 position relative to the known
caspase-cleavage site Asp29 between the prodomain and the
large catalytic subunit (Figure 5G). Cleavage at this site is
thought to occur primarily by autocatalytic processing; however,
there is some evidence that caspase-8 also proteolyzes this site
(Rank et al., 2001). As we found for KHSRP and RB1, caspase-8
displayed markedly greater hydrolytic activity for the phosphor-
ylated versus unphosphorylated caspase-3 peptide (Figure 5H).
These results, taken together, indicate that phosphorylation
can promote the caspase cleavage of proteins during apoptosis
primarily through a mechanism involving the P3 position of
caspase proteolytic sites, which, upon phosphorylation, dramat-
ically increases substrate hydrolysis by caspase-8.
DISCUSSION
The potential for crosstalk between phosphorylation and proteo-
lytic pathways in apoptosis and other cell biological processes
has long been recognized (Kurokawa and Kornbluth, 2009;athways in Apoptosis
cells. 210 proteins observed in our data that contain known sites of caspase
ber of phosphorylation sites detected ±200 residues are shown. The region of
.
ed proteins.
r post-STS treatment relative to kinase activities measured in control cells (see
t).
on events as determined by the motif-x algorithm (also see Table S4).
tifs following induction of apoptosis.
is responsible for the apoptosis-related increase in p[S/T]-Q events.
treatment. The C-terminal persistent fragment contains the PI-3-kinase-like
cleaved and a C-terminal fragment containing the kinase domain translocates
PK match closely the kinetics of DNA-PK activation as measured by KiNativ
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Table 1. Apoptosis-Specific Phosphorylation Sites Found within Six Residues (P6–P60) of Caspase Cleavage Sites
IPI Number Symbol Phosphosite Sequence Position
IPI00007423 ANP32B 158 S*DAEVDjGVDEEE P6
IPI00032064 PALM2-AKAP2 698 T*QEELDjSGLDEL P6
IPI00794135 SPTBN1 1454 S*TDEVDjSKRLTV P6
IPI00004363 STK39 387 S*DDEMDjEKSEEG P6
IPI00438229 TRIM28 683 S*LDGADjSTGVVA P6
IPI00465428 VPS13C 1400 S*QDVHDjSKNTLT P6
IPI00026156 HCLS1 111 HS*SQTDjAAKGFG P5
IPI00003168 PRPSAP2 219 ES*DLVDjGRHSPP P5
IPI00302829 RB1 882 GS*DEADjGSKHLP P5
IPI00026156 HCLS1 112 HSS*QTDjAAKGFG P4
IPI00376199 IRF2BP2 492 PAS*LPDjSSLATS P4
IPI00029822 SMARCA4 699 DVS*EVDjARHIIE P4
IPI00292140 CASP3 26 GSES*MDjSGISLD P3
IPI00855957 KHSRP 100 NNST*PDjFGFGGQ P3
IPI00604620 NCL 591 LKES*FDjGSVRAR P3
IPI00026940 NUP50 246 TEDT*PDjKKMEVA P3
IPI00302829 RB1 347 QTDS*IDjSFETQR P3
IPI00745092 SPTAN1 1484 KGDS*LDjSVEALI P3
IPI00178440 EEF1B2 153 WDDET*DjMAKLEE P2
IPI00395014 RSRC1 237 EAIES*DjSFVQQT P2
IPI00221106 SF3B2 861 KEDFS*DjMVAEHA P2
IPI00329528 VPRBP 1421 DDDDT*DjDLDELD P2
IPI00304171 H2AFY 173 KAASADjS*TTEGT P10
IPI00745092 SPTAN1 1484 TEDKGDjS*LDSVE P10
IPI00219913 USP14 228 SVKETDjS*SSASA P10
IPI00604620 NCL 595 LKESFDjGS*VRAR P20
IPI00397904 NUP93 159 GEDALDjFT*QESE P20
IPI00219913 USP14 229 SVKETDjSS*SASA P20
IPI00166394 ARMC10 89 PEDLTDjGSY*DDV P30
IPI00747447 EIF3B 164 PEDFVDjDVS*EEE P30
IPI00102670 FNBP1 522 DRESPDjGSY*TEE P30
IPI00028065 NCK1 91 KPSVPDjSAS*PAD P30
IPI00221106 SF3B2 302 EEMETDjARS*SLG P30
IPI00219913 USP14 230 SVKETDjSSS*ASA P30
IPI00455210 CHD4 367 EVTAVDjGYET*DH P40
IPI00000856 PLEKHC1 351 EVDEVDjAALS*DL P40
IPI00604620 NCL 206 DEDDDDjDEEDDS* P60
IPI00163505 RBM39 337 VTERTDjASSASS* P60
See Table S1 for corresponding peptographs of the proteins.Lo´pez-Otı´n and Hunter, 2010); however, investigating such
network interactions at a global level has proven technically chal-
lenging due to the lack of proteomic technologies that can coor-
dinately profile protein phosphorylation and proteolysis in cells.
qP-PROTOMAP addresses this problem by quantifying phos-
phorylation events in proteomes and incorporating these modifi-
cations into the topographical maps of proteins such that their
relationship to proteolytic processing can be directly inferred.
Using this approach, we have uncovered several ways that434 Cell 150, 426–440, July 20, 2012 ª2012 Elsevier Inc.phosphorylation and proteolytic pathways intersect in apoptotic
cells. This crosstalk is evident on a global level by the enrichment
of phosphorylation events on proteolyzed proteins at locations
that are in close proximity to caspase cleavage sites. From a
functional perspective, we show that caspase cleavage can
unveil new sites for phosphorylation on proteins and, conversely,
apoptosis-specific phosphorylation events at the P3 position of
caspase recognition sites can promote the cleavage of proteins
(Figure 6). Caspase cleavage can also activate kinases, like
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Figure 4. Caspase Cleavage Exposes New Sites for Phosphorylation
(A and B) Quantitative peptographs showing SF3B2 at 2 hr (A) and 4 hr (B) post-STS treatment. A C-terminal apoptosis-specific phosphorylation event at Ser861
occurs at the P2 position relative to the caspase cleavage site at Asp862. An additional apoptosis-specific phosphorylation event is observed at Ser289 on the
parental form of SF3B2 (band 3) at 2 hr, which is 10 residues from another site of caspase cleavage (Asp299, see band 13 in B).
(C) MS-based quantitation showing that the cleaved/unphosphorylated (Ser861) SF3B2 peptide is generated prior to the cleaved/phosphorylated (pSer861)
peptide during apoptosis. Quantified peptides: uncleaved/unphosphorylated - EQQAQVEKEDFSDMVAEHAAK, uncleaved/phosphorylated - EQQAQVEKEDFS*
DMVAEHAAK (endogenous form not detected), cleaved/unphosphorylated - EQQAQVEKEDFSD, cleaved/phosphorylated - EQQAQVEKEDFS*D.
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DNA-PK, that contribute to the creation of a network of phos-
phorylation events that are specific to apoptotic cells (Figure 6).
This network is enriched in phosphorylation events that lack liter-
ature precedent, further supporting their potentially special rela-
tionship to the cell death process.
Although we do not yet understand precisely how caspase
cleavage promotes the phosphorylation of proteins, it is possible
that the kinases responsible for these phosphorylation events
cannot gain access to their substrates due to steric hindrance.
Caspase cleavage at a proximal location along the protein back-
bone could then relieve this steric blockade to expose sites for
phosphorylation (Figure 6). Alternatively, there may be kinases
that selectively phosphorylate proteins near their N or C termini,
although we are not aware of any specific kinases that have been
reported to show this substrate preference. Finally, it is possible
that cleavage promotes the redistribution of kinases like DNA-PK
to distinct subcellular compartments where they phosphorylate
new sets of substrates.
Phosphorylation events that promote proteolysis were found
to occur at the P3 position relative to caspase cleavage sites,
where they dramatically enhanced substrate hydrolysis by
caspase-8. This finding is unexpected and important because
phosphorylation events within caspase consensus motifs
(P4–P10 residues) have, in the past, been found to hinder cas-
pase cleavage (Kurokawa and Kornbluth, 2009). Our results
are, however, consistent with previous structural work on cas-
pases, which have shown that caspase-8, as well as caspase-9,
possess a unique arginine residue not found in other caspases
that enhances binding to substrates with acidic residues in the
P3 position (Blanchard et al., 2000; Che´reau et al., 2003;
Fuentes-Prior and Salvesen, 2004). This feature has historically
been interpreted to explain the preference that caspase-8
displays for substrates with a P3 glutamic acid residue
(Fuentes-Prior and Salvesen, 2004), but our data suggest
another level of biological significance, namely, that caspase-8
may have evolved to recognize a set of substrates selectively
in their phosphorylated state. We should mention, however,
that so far, we have only assessed the impact of P3-phosphory-
lation on a handful of caspase substrates, and it is therefore not
yet clear whether P3-phosphorylation will serve as a general
or substrate-selective mechanism to enhance proteolysis by
caspase-8.
The intricate, systems-level interactions between kinase
and caspase networks uncovered by qP-PROTOMAP analysis
of apoptotic cells sets the stage for several important lines
of future research. First, we have only examined one cell line
(Jurkat T cells) and its response to a single apoptotic stimulus
(STS). Although the rapid and near-complete apoptotic pro-(D) In vitro peptide substrate assays (1 mM peptide substrate) demonstrating
Peptide substrates: EQQAQVEKEDFSDMVAEHAAK and EQQAQVEKEDFS*DMV
(E) Quantitative peptograph of HCLS1 showing an apoptosis-specific phosphory
at Asp115.
(F) In vitro peptide substrate assays (1 mM peptide substrate) demonstrating t
and hinders proteolysis by caspase-8. Peptide substrates: SAVGHEYVAEV
SAVGHEYVAEVEKHSSQTD and SAVGHEYVAEVEKHSS*QTD.
See also Figure S3. For (D) and (F) error bars represent the SEM.
436 Cell 150, 426–440, July 20, 2012 ª2012 Elsevier Inc.gression observed in STS-treated Jurkat cells has made it
a preferred model for cell biological and proteomic investiga-
tions of programmed cell death (Dix et al., 2008; Mahrus
et al., 2008; Short et al., 2007), and a recent study has shown
that different apoptotic stimuli (STS versus TRAIL) cause similar
overall patterns of protein cleavage in cells (Agard et al., 2012),
assessing the broader significance of our findings would
certainly benefit from qP-PROTOMAP studies of additional
cell types and with distinct apoptotic stimuli. Second, we do
not yet fully understand which kinases are responsible for the
phosphorylation events observed specifically in apoptotic cells.
Although our results indicate that DNA-PK makes a substantial
contribution to this apoptosis-specific phosphorylation net-
work, many of its constituent phosphorylation events do not
conform to the [S/T]-Q motif preferred by DNA-PK (Figure S2),
pointing to the potential activation of other kinases (or inactiva-
tion of phosphatases) during apoptosis. Our functional proteo-
mic data suggest candidates like AKT1 and 2, MAPK14, and
BRAF for future investigation (Figure 3C). Disrupting such
kinases could reveal the functional contribution that they (and
their cognate substrates) make to apoptosis, as has been
shown previously for DNA-PK (Bharti et al., 1998; Chakravarthy
et al., 1999; Chen et al., 2005a, 2005b; Wang et al., 2000).
Finally, there are other potential forms of crosstalk between
phosphorylation and proteolytic pathways that may have
eluded detection in our study. Phosphorylation events that,
for instance, block caspase cleavage would not have been
easily identified because the resulting phosphoprotein would
not be detected as a cleaved product. Future studies that
compare the apoptotic process under different cellular condi-
tions may reveal context-dependent changes in protein
cleavage that are due to such ‘‘protective’’ phosphorylation
events. In fact, others have speculated, for instance, that
cancer cells displaying resistance to apoptosis may possess
specific kinase networks that mark proteins with phosphoryla-
tion events that protect against caspase cleavage (Ahmed
et al., 2002). The qP-PROTOMAP method described herein
represents a versatile proteomic platform for addressing such
questions through its ability to generate global, quantitative,
and integrated profiles of phosphorylation and proteolytic path-
ways in biological systems.
EXPERIMENTAL PROCEDURES
Cell Culture and Induction of Apoptosis
Jurkat cells were grown under standard conditions and seeded to a density of
13 106 cells/ml prior to induction of apoptosis. Staurosporine (1 mM final) was
added and the cells were incubated for 2 or 4 hr at 37C prior to lysis. See
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Figure 5. Phosphorylation at the P3 Position of Caspase Cleavage Sites Promotes Caspase-8-Mediated Proteolysis
(A and B) Quantitative peptographs showing an apoptosis-specific phosphorylation event at Thr100 on the parental form of KHSRP (A, band 6/7) at 2 hr, and on
a half-tryptic, aspartate (Asp103)-terminating peptide of a stable fragment of this protein at 4 hr (B, band 21). Note that this half-tryptic peptide is shown in gray
because it lacks an isotopically labeled amino acid.
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Figure 6. Mechanisms of Crosstalk
between Phosphorylation and Proteolytic
Pathways in Apoptosis
Several distinct forms of crosstalk between
caspase and kinase pathways were uncovered by
qP-PROTOMAP: (1) kinases (such as DNA-PK)
can be cleaved and activated by caspases; (2)
caspase cleavage can expose previously oc-
cluded residues that are then phosphorylated by
kinases; (3) phosphorylation at the P3 position
relative to scissile aspartates promotes proteolysis
of proteins by caspase-8. This type of proteolysis-
promoting P3 phosphorylation was also found on
caspase-3 itself (4).Sample Preparation, SDS-PAGE, and Mass Spectrometry
400 mg of cytosolic protein (200 mg + 200 mg of light and heavy protein) was
separated via a 10% SDS-PAGE gel and cut into 22 0.5 cm bands. Peptides
were extracted via in-gel trypsin digestion and subjected to immobilized
metal affinity chromatography (IMAC). IMAC eluate (enriched in phosphopep-
tides) or flow-through (for unphosphorylated peptides) was loaded onto(C) MS-based quantitation showing a rapid increase in the uncleaved/phosphorylated (pThr100) KHSRP pep
which is 1 hr prior to the appearance of the cleaved forms of this peptide. Note that the uncleaved/unphos
higher levels than the other peptides and was therefore not shown in the figure for the sake of clarity (se
uncleaved/unphosphorylated - IGGDAATTVNNSTPDFGFGGQK, uncleaved/phosphorylated - IGGDAATTVN
IGGDAATTVNNSTPD, cleaved/phosphorylated - IGGDAATTVNNST*PD.
(D) In vitro peptide substrate assays (1 mMpeptide substrate) demonstrating that phosphorylation at Thr100 of
substrates: IGGDAATTVNNSTPDFGFGGQK and IGGDAATTVNNST*PDFGFGGQK. Peptide products: IGGD
(E) Structure of caspase-8 (PDB: 1QTN) with the tetrapeptide ST*PD modeled into the active site. See the Ex
additional details.
(F) In vitro peptide substrate assays (1 mM peptide substrate) demonstrating that phosphorylation at Ser882
a lesser extent, by caspase-3. Peptide substrates: TLQTDSIDSFETQR and TLQTDS*IDSFETQR. Peptide pr
(G) Quantitative peptograph showing caspase-3 at 2 hr post-STS treatment, revealing an apoptosis-specifi
position relative to the known caspase cleavage site at Asp28.
(H) In vitro peptide substrate assays (1 mMpeptide substrate) demonstrating that phosphorylation at Ser26 pro
a lesser extent, by caspase-3. Peptide substrates: IIHGSESMDSGISLDNSYK and IIHGSES*MDSGISLDNSYK
See also Figure S4. For (D), (F), and (H), error bars represent the SEM.
438 Cell 150, 426–440, July 20, 2012 ª2012 Elsevier Inc.a 100 mm (inner diameter) fused silica capillary
column containing C18 resin, and eluted directly
into an LTQ-Velos Orbitrap mass spectrometer
operated in data-dependent scanning mode,
with one full MS scan in the Orbitrap (60,000 reso-
lution) followed by ten MS2 scans in the ion trap.
See Extended Experimental Procedures for more
detail.
Data Analysis
MS2 data were searched using the ProLuCID algo-
rithm (Xu et al., 2006) with a reverse-concate-
nated, nonredundant variant of the human IPI
database. Peptides from each gel-band were
grouped and filtered using DTASelect (Tabb
et al., 2002), SILAC ratios were obtained with
Cimage (Weerapana et al., 2010), and these data
were assembled into quantitative peptographs
using custom software. The ‘‘phosphorylation
site data set’’ released on November 3, 2011
from the PhosphoSite database (Hornbeck et al.,
2011) was used for assessments of phosphosites.
The CASBAH database (Lu¨thi and Martin, 2007)
was downloaded on December 19, 2011 andused for assessments of caspase-substrates. See Extended Experimental
Procedures for more detail.
Caspase Activity Assays with Synthetic Peptide Substrates
Recombinant human caspases were diluted into buffer containing substrate
peptide and an internal standard, and incubated for 1–2 hr at 37C. Assaystide (yellow line) from 0 to 2 hr post-STS treatment,
phorylated KHSRP peptide was found at ten times
e Figure S4 for these data). Quantified peptides:
NST*PDFGFGGQK, cleaved/unphosphorylated -
KHSRP enhances cleavage by caspase-8. Peptide
AATTVNNSTPD and IGGDAATTVNNST*PD.
tended Experimental Procedures and Figure S4 for
of RB1 promotes cleavage by caspase-8 and, to
oducts: TLQTDSID and TLQTDS*ID.
c phosphorylation event at Ser26, which is the P3
motes cleavage of caspase-3 by caspase-8 and, to
. Peptide products: IIHGSESMDand IIHGSES*MD.
were quenched by acidification and subjected to ZipTip purification before MS
analysis. Absolute quantities of product were calculated by comparison to
synthetic standards. Assays were performed under nonsaturating substrate
concentrations and resulted in less than 20% turnover of the substrate. See
Extended Experimental Procedures for more detail.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and five tables and can be found with this article online at http://
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